bibliographic entry 7573942 [be/7573942]
https://w3id.org/oc/corpus/be/7573942

is a

• bibliographic reference

content

• Haering, HU, Merker, L, Seewaldt-Becker, E, Weimer, M, Meinicke, T, Broedl, UC, Woerle, HJ. EMPA-REG MET Trial Investigators. Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2014; 37: 1650–1659. PMID: 24722494

references

• https://w3id.org/oc/corpus/br/88239